Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03894215
Title Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Agenus Inc.
Indications

cervical adenosquamous carcinoma

cervical squamous cell carcinoma

cervical adenocarcinoma

Therapies

Balstilimab

Balstilimab + Zalifrelimab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.